A Saugus man has been sentenced to a 15-year prison term following his conviction for drug conspiracy and a firearm offense. Yesterday, the U.S. Attorney's Office for the District of Massachusetts announced that Aaron Lenardis, 38, received his sentence from U.S. District Court Judge Leo T. Sorokin. His sentence also includes five years of supervised release post-incarceration. According to the U.S. Justice Department, Lenardis was found guilty last November for his involvement in a conspiracy to distribute significant amounts of methamphetamine and fentanyl.
The investigation that led to Lenardis's conviction began in August of 2022. Lenardis and his co-conspirator Charles Bates were implicated in the manufacture of tens of thousands of counterfeit pills. Bates was observed picking up an orange binding agent, used for creating fake Adderall pills, which was then transported to Lenardis’s residence to produce these pills. Bates's contribution to the conspiracy and his subsequent sentencing to 10 years in prison was previously reported.
Details of the operation emerged during the investigation, including Bates's text messages discussing the pill manufacturing process. He claimed to be present while the pills were made, assuring that "no corners have been cut." These messages, according to the Justice Department's release, also noted the extensive use of a pill press that could produce up to 5,000 pills an hour.
An October 2022 search of Lenardis's home resulted in the seizure of a an industrial pill press, 14 firearms including a modified Glock, as well as considerable amounts of drugs, including pills and powder containing methamphetamine and fentanyl. The operation involved at least 136,000 counterfeit pills that were equivalent to around 40 kilograms of methamphetamine-related drugs.
The prosecution of the case was carried out by Assistant U.S. Attorneys Samuel R. Feldman and Charles Dell’Anno of the Narcotics & Money Laundering Unit. United States Attorney Leah B. Foley and Stephen Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration's New England Field Division also played a key role in making the announcement of this sentencing. Lenardis's conviction underscores the ongoing battle against the illicit drug trade, particularly in the realm of counterfeit pharmaceuticals.
